DEFAZIO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 10.223
AS - Asia 3.537
EU - Europa 2.137
SA - Sud America 998
AF - Africa 159
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.065
Nazione #
US - Stati Uniti d'America 10.123
SG - Singapore 1.556
BR - Brasile 817
CN - Cina 762
HK - Hong Kong 510
IT - Italia 311
UA - Ucraina 297
DE - Germania 292
SE - Svezia 271
RU - Federazione Russa 241
FI - Finlandia 230
FR - Francia 192
VN - Vietnam 178
GB - Regno Unito 124
IN - India 110
BD - Bangladesh 73
AR - Argentina 57
CA - Canada 50
CI - Costa d'Avorio 49
IQ - Iraq 49
EC - Ecuador 41
BE - Belgio 40
TR - Turchia 37
IE - Irlanda 32
PK - Pakistan 32
ID - Indonesia 31
ZA - Sudafrica 30
MX - Messico 28
CO - Colombia 25
TW - Taiwan 23
SA - Arabia Saudita 22
PL - Polonia 21
MA - Marocco 19
VE - Venezuela 19
ES - Italia 18
IR - Iran 18
PH - Filippine 18
JP - Giappone 17
AE - Emirati Arabi Uniti 15
CL - Cile 14
NL - Olanda 13
TN - Tunisia 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
MY - Malesia 10
AT - Austria 9
EG - Egitto 9
JO - Giordania 9
KE - Kenya 9
LU - Lussemburgo 8
ET - Etiopia 7
PE - Perù 7
PY - Paraguay 7
AU - Australia 6
AZ - Azerbaigian 6
DZ - Algeria 6
JM - Giamaica 6
KR - Corea 6
UY - Uruguay 6
AL - Albania 5
LB - Libano 5
NG - Nigeria 5
NP - Nepal 5
BH - Bahrain 4
BO - Bolivia 4
IL - Israele 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
SN - Senegal 4
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
GY - Guiana 1
HN - Honduras 1
Totale 17.052
Città #
Fairfield 1.320
Woodbridge 1.039
Ashburn 817
Singapore 753
Houston 654
Jacksonville 645
Chandler 633
Seattle 531
Hong Kong 510
Cambridge 433
Ann Arbor 423
Wilmington 388
San Jose 380
Dallas 280
Lawrence 165
Nanjing 165
Roxbury 165
Lauterbourg 164
Beijing 153
Nyköping 149
New York 125
Des Moines 110
Boardman 103
Los Angeles 93
Princeton 85
São Paulo 64
Ho Chi Minh City 63
Buffalo 55
Helsinki 55
San Diego 54
Abidjan 49
Nanchang 46
Shenyang 45
Inglewood 43
Hebei 40
Santa Clara 39
Bari 37
Hanoi 36
Brooklyn 34
Brussels 34
Chicago 32
Dublin 32
Jiaxing 29
Rio de Janeiro 25
Falkenstein 24
Nuremberg 23
Taipei 22
Baghdad 21
Munich 21
Chennai 19
Quito 19
Rome 19
Warsaw 18
Atlanta 17
Frankfurt am Main 17
San Mateo 17
Changsha 16
Johannesburg 16
London 16
Norwalk 16
Tokyo 16
Belo Horizonte 15
Campinas 15
San Francisco 15
Augusta 14
Brasília 14
Curitiba 14
Dhaka 14
Montreal 14
Tianjin 14
Toronto 14
Turku 14
Dearborn 13
Milan 13
Naples 13
Ribeirão Preto 13
Council Bluffs 12
Orem 12
Pune 12
Tashkent 12
Brno 11
Guangzhou 11
Guayaquil 11
Istanbul 11
Leawood 11
Riyadh 11
Stockholm 11
Ardabil 10
Fortaleza 10
Jakarta 10
Mexico City 10
Porto Alegre 10
Santo André 10
Medellín 9
Turin 9
Belvaux 8
Boston 8
Denver 8
Haiphong 8
Lahore 8
Totale 11.864
Nome #
Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile 208
Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs 193
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 187
Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings 168
Antineuronal antibody status and phenotype analysis in Tourette's syndrome 154
A comparative study of primary and secondary hemifacial spasm 152
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 149
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 148
Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population 148
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 144
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 144
Personality disorders and somatization in functional and organic movement disorders 143
Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm 142
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 142
Antineuronal antibodies in cranial dystonia. 141
No association between essential tremor and migraine: A case-control study 139
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 139
Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials 136
Abnormal tactile temporal discrimination in psychogenic dystonia 131
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 131
Onset and spread of dyskinesias and motor symptoms in Parkinson's disease 129
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study 129
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 128
A family study on primary blepharospasm 128
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment 127
Relationship between eye symptoms and blepharospasm: a multicenter case-control study 127
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders 126
"Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report 126
Camptocormia in Parkinson disease: an epidemiological and clinical study 124
Post-streptococcal 'complex' movement disorders: unusual concurrence of psychogenic and organic symptoms 124
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. 122
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort 121
The natural history of treated PD in an incident, community-based cohort: does the future begin? 121
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia 120
Headache in cranial and cervical dystonia 119
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia 117
La tossina botulinica nel recupero del piede equino-valgo da paralisi cerebrale infantile 117
Development and validation of a clinical guideline for diagnosing blepharospasm 115
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 115
Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing 114
Endocytosis of horseradish peroxidase by brain microvascular and umbilical vein endothelial cells in culture: an ultrastructural and morphometric study 114
EPIDEMIOLOGY OF PRIMARY BLEPHAROSPASM 113
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 113
Disease modeling in functional movement disorders 111
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm 108
Epidemiology of primary dystonia 108
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture 108
Psychiatric disorders in patients with essential tremor 108
Epidemiology of primary and secondary dystonia 107
The epidemiology of pain in Parkinson's disease 106
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a 106
Pain and motor complications in Parkinson's disease 105
Antinflammatory effects of rIFNb-1b in multiple sclerosis: longitudinal changes of the serum soluble Intercellular Adhesion Molecule-1 (sICAM-1), TNFa and T-cell subsets 105
Pathophysiology of somatosensory abnormalities in Parkinson disease. 105
Is increased blinking a form of blepharospasm? 104
Influence of age on the association between primary hemifacial spasm and arterial hypertension 103
The epidemiology of primary dystonia: current evidence and perspectives 103
Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease 102
Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study 102
Eye symptoms in relatives of patients with primary adult-onset dystonia 102
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? 102
Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture 101
How pain arises in Parkinson's disease 101
Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm 101
Botulinum A toxin for the so-called apraxia of lid opening 101
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24) 101
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia 100
Sleep and cranial dystonia 99
Quality of sleep in primary focal dystonia: a case-control study 99
Do primary adult-onset focal dystonias share aetiological factors? 98
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia 98
Ataxia in posterior circulation stroke: clinical-MRI correlations 98
Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials 98
Mirror movements in patients with Parkinson's disease 98
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor 97
Primary Cervical dystonia and scoliosis: a multicenter case-control study 97
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene 96
Fatigue in Parkinson's disease 96
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group 96
Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening 96
Time processing in children with Tourette's syndrome 95
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria . 95
The influence of electroencephalographic focus laterality on efficacy of carbamazepine in complex partial and secondarily generalized tonic-clonic seizures 95
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 95
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 95
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder 95
Long-term assessment of the risk of spread in primary late-onset focal dystonia 94
Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia 94
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia 94
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 93
Blepharospasm in bardet-biedl syndrome: a case report 93
Primary hemifacial spasm and arterial hypertension: a multicenter case-control study 92
Soluble adhesion molecules in Gilles de la Tourette's syndrome 92
Epidemiology of primary and secondary dystonia 91
Does sex influence age at onset in cranial-cervical and upper limb dystonia? 91
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels 89
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials 89
Epidemiology of primary blepharospasm 89
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 89
Tracing Sydenham's chorea: historical documents from a British paediatric hospital 88
Totale 11.442
Categoria #
all - tutte 64.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 0 0 0 0 208 156 84
2021/2022949 45 68 5 35 58 96 29 47 104 90 163 209
2022/20231.499 272 122 46 172 221 204 7 148 236 5 36 30
2023/2024630 51 113 27 119 35 140 4 19 2 11 29 80
2024/20252.382 34 41 223 76 51 176 161 190 99 111 387 833
2025/20264.852 712 250 455 473 511 349 616 231 757 498 0 0
Totale 17.364